This inventor holds 2 USPTO granted patents and 1 published patent application. Top assignees: Centre National De La Recherche Scientifique, Ucl Business Plc, Ureka Sarl. Active years: 2016-2019.
Company Filing History:
1 out of 5,383 
1 out of 299 
1 out of 6 Years Active: 2016-2019
Title: Gavin William Collie: Innovator in Therapeutic Compounds
Introduction
Gavin William Collie is a notable inventor based in Aberdeenshire, GB. He has made significant contributions to the field of therapeutic compounds, holding two patents that showcase his innovative spirit and dedication to advancing medical science.
Latest Patents
Collie's latest patents include the "Foldamer helix bundle-based molecular encapsulation." This invention provides compositions and methods for producing therapeutic oligomeric compounds. It also outlines methods for administering these compounds for the treatment and prevention of diseases in mammals. The disclosure particularly relates to medicaments comprising various novel oligomeric compounds and their pharmaceutically acceptable salts. Additionally, he has developed "Diimide compounds," which are novel naphthalene diimides used in therapy, especially for cancer treatment.
Career Highlights
Throughout his career, Gavin has worked with reputable organizations such as Ureka Sarl and the Centre National De La Recherche Scientifique. His work in these institutions has allowed him to explore and develop innovative solutions in the field of therapeutic compounds.
Collaborations
Gavin has collaborated with esteemed colleagues, including Gilles Guichard and Karolina Pulka-Ziach. These partnerships have contributed to the advancement of his research and the successful development of his patents.
Conclusion
Gavin William Collie's contributions to the field of therapeutic compounds highlight his innovative approach and commitment to improving healthcare. His patents reflect a deep understanding of medicinal chemistry and a desire to make a positive impact on disease treatment.